𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Indications and limitations of liver transplantation for hepatocellular carcinoma

✍ Scribed by Wudel, L.James; Chapman, William C

Book ID
121781016
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
234 KB
Volume
12
Category
Article
ISSN
1055-3207

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver transplantation for non–hepatocell
Liver transplantation for non–hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature
✍ Eric J. Grossman; J. Michael Millis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 497 KB

Orthotopic liver transplantation (OLT) is currently incorporated into the treatment regimens for specific nonhepatocellular malignancies. For patients suffering from early-stage, unresectable hilar cholangiocarcinoma (CCA), OLT preceded by neoadjuvant radiotherapy has the potential to readily achiev

Toward optimizing the indications for or
Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma
✍ Didier Samuel; Massimo Colombo; Hachem El-Serag; Rodolphe Sobesky; Nigel Heaton πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## Key Points 1. Liver transplantation is currently an effective therapy for patients with HCC who meet the Milan criteria. 2. The proportion of patients on waiting lists for liver transplantation who have HCC has increased substantially in recent years. HCC is currently one of the major indicatio

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma
✍ Alan P. Venook πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 277 KB πŸ‘ 1 views

Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable